Page 1933 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

1360 Index

Vasopressin in Septic Shock Trial Ventilator-induced lung injury, 434–435, 434f, special effects of altered afterload on
(VASST), 263 439–448, 439t, 440t, 470 ventricular function in critical
Vasopressors, 252–253, 572–573, 1145 acute respiratory distress syndrome and, illness, 274–275
Vasospasm, 243, 777 439–440 valvular dysfunction, 275
VCAM-1, 908 biotrauma, 444 mechanisms and management of right
Vegetative state, 829–830 decompartmentalization, 444–445 ventricular dysfunction, 275–276
VEGF-targeted tyrosine kinase high airway pressures/large tidal volumes decreased right ventricular systolic
inhibitors, 897 and, 441–442, 441f, 442f function, 275
Vena caval interruption, 329 lung-protective strategies, do no harm, disorders of right ventricular preload,
Venezuelan equine encephalitis virus 445–447, 446t afterload, valves and rhythm,
(VEEV), 673 macroscopic injury, 440 275–276, 276t
Venezuelan hemorrhagic fever, 739 rescue therapies for life-threatening hypoxia ventricular interaction, 276
Veno-arterial extracorporeal membrane minimizing vili, 447–448, 448f Ventricular dysrhythmias, 1177
oxygenation (ECMO), 474 role of end-expiratory pressure, Ventricular fibrillation and pulseless VT, 286
Venoocclusive disease, 223 442–444, 443f Ventricular fibrillation/ventricular tachycardia
Venous air embolism, in pregnancy, Ventilator management of respiratory without a pulse, 169–170
1266–1267 abnormalities, 458–459, 458f, 459f, Ventricular filling disorders, diastolic V-P
Venous oximetry, 243–244, 244t 460f, 461ft, 462t, 463ft, 464t, curve and, 231, 231ft
Venous oxygen saturation, sepsis 465t, 467f Ventricular free wall rupture, 305
and, 569 Ventilator waveforms, 411–424 Ventricular hypertrophy, 310
Venous return to facilitate lung-protection in acute Ventricular interaction, diagnosis of
cardiac function curves and, 233–234, respiratory distress syndrome, interdependence, 276
233f, 234f 420–421, 420f, 421f Ventricular interdependence, treatment of, 276
control of, by systemic vessels, 269–270 flow waveforms, 414–415, 415f Ventricular proarrhythmia, risk of, 279
decreased, 254–256, 255f hemodynamic interpretation and, Ventricular septal rupture, 305
resistance to, 234, 234f 421–422, 421f, 422f Ventricular tachyarrhythmias, 280–286, 281f,
Venous thromboembolism, 221, 560 obstructed patient, 415–418, 415f, 416f, 282t, 283t, 284ft, 285f, 286f
in pregnancy, 1268 417f, 418f management of, 283–286, 284ft
prophylaxis, 1135–1136 patient asynchrony, 418, 419f, Ventricular tachycardia with a pulse, 169
prophylaxis against, 332–333 420, 420f Ventricular-vascular coupling, 229–230, 229f
reducing risk of recurrence, 221 pressure at the airway opening, 412–414, Ventriculostomy infections, 1136
Venturi effect, 1069
risk of, 1308 https://kat.cr/user/tahir99/
412f, 423ft
spinal injuries and, 1151 unusual problems revealed by analysis, Vertebral injuries, classification of,
stress ulcer prophylaxis, sepsis 423, 423f 1138–1139, 1140t
and, 575 Ventilatory failure, 250–251 Viatorr™ stent, 224
Venous thrombosis, 319f, 320f, 321f hypoxemic versus, 372, 373t Vibrio cholerae, in noninflammatory
Venous ultrasonography, in diagnosing Ventilatory impairment, diseases of, 974 diarrhea, 706
pulmonary embolic disorders, 325 Ventricular dysfunction in critical illness, Video capsule endoscopy, 1021
Ventilated patient 229–233, 229f, 230f, 231ft, 266–278 Vigileo™, 248
cardiopulmonary interactions, 425 acute on chronic heart failure, 276–277, 277t Viral hemorrhagic fevers, 717–718, 733–743,
choosing ventilator mode, 425–430, clinical features, 277 734–7353, 736t, 750–751
428f, 429f management of, 277 dengue as, 717–718
management of, 424–434, 430–433, precipitating factors, 276–277 Ebola/Marburg as, 718
431f, 432ft assessment of cardiac dysfunction, flaviviridae as, 734–736, 738
prevention, the ventilator bundle, 424 266–269, 266f hantavirus as, 718
ventilator-induced diaphragm central venous and right heart catheters, Viral infections, 1300–1302
dysfunction, 425 268 herpes simplex, 1300, 1300ft, 1301f
ventilator-induced lung injury, 425 clinical examination, 266, 267t human immunodeficiency virus, 1302, 1302t
Ventilation perfusion lung scan, in echocardiographic examination, smallpox, 1302
diagnosing pulmonary embolic 266–268 varicella zoster, 1300–1302, 1301f
disorders, 325–326 decreased cardiac output due to cardiac Virtual autopsy, 36
Ventilator, management during dysfunction or decreased venous Visceral abscess, 1082–1083, 1082t, 1083f
ECMO, 475 return, 268–270 VISICU system, assessing, 17
Ventilator-associated pneumonia (VAP), control of venous return by systemic Vitamin K antagonists, 854–855
388, 424, 520–535, 570, 629 vessels, 269–270 Volume, 252
diagnosis of, 525–529, 526f, 527f definition of cardiac pump function Volume feedback control of pressure-targeted
difficulty in diagnosing, 14 and its relation to venous return, breaths, 437
epidemiology of, 521–522, 522t 268–270 Volume responsiveness, detection of, 243
evidence of, 46 ventricular systolic and diastolic VolumeView, 247
predisposing factors, 522–525, 523t function, 268–269, 269f Von Willebrand disease, 846, 854
prevention, 532–535 mechanisms and management of left Von Willebrand factor (VWF)
sensitive indicator for, 8 ventricular dysfunction, 270–275 deficiency of, 854
treatment of, 529–532 abnormal heart rate and rhythm, 275 qualitative deficiency of, 846
Ventilator discontinuation process, decreased left ventricular systolic Von Zumbusch psoriasis, 1292–1293, 1292f
patient ventilator synchrony, contractility, 270–273, 271f, 272t Voriconazole, 649–650
435, 435f increased diastolic stiffness, 274 VT/VF electrical storm, 286

Index.indd 1360 23-01-2015 15:33:54